Governing Council Fifty-fourth Session GC[removed]

First Page		Document Content
Date: 2012-11-16 05:03:41 Human papillomavirus Cervical cancer Cancer Breast cancer Epidemiology of cancer Head and neck cancer HPV vaccine HPV-positive oropharyngeal cancer Medicine Oncology Papillomavirus		Governing Council Fifty-fourth Session GC[removed] Add to Reading List Source URL: governance.iarc.fr. Download Document from Source Website File Size: 66,59 KB Share Document on Facebook

	Date: Head and Neck Cancer Alliance PO BoxCharleston, SCDear Head and Neck Cancer Alliance: DocID: 1tlbA - View Document
	AbstractProspective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC DocID: 1rVAJ - View Document
	Lettre d’information du réseau GCO - Spéciale ASCOLes Groupes Coopérateurs en Oncologie à l’ASCO 2016 Les Groupes Coopérateurs en Oncologie (GCO) seront représentés au 52ème congrès de l’ASCO (Ameri DocID: 1qX2r - View Document
	Nutrition and Cancer: Frontiers for Cure! Gregory K. Ogilvie, DVM Diplomate ACVIM (Specialties of Internal Medicine and Oncology), Professor of Oncology and Internal Medicine Animal Cancer Center, Medical Oncology Resear DocID: 1q8XC - View Document
	ENGLISH SUMMARY Persistent high-risk HPV infection has been associated with the development of cervical, vaginal, vulvar, anal and penile cancers, although the proportions attributable to HPV vary by cancer site. Lately, DocID: 1pUdx - View Document